Bausch + Lomb Corporation (NYSE:BLCO) Given Consensus Rating of "Hold" by Analysts

Key Points

• Bausch + Lomb Corporation has received a consensus recommendation of "Hold" from eleven research firms, with one sell, seven hold, and three buy ratings.
• The company reported a quarterly revenue of $1.28 billion, exceeding analyst estimates, and a 0.07 EPS, beating the consensus estimate by $0.01.
• Recent institutional trading shows significant investments, with Deutsche Bank acquiring a new stake worth approximately $50.75 million in Bausch + Lomb.

Bausch + Lomb Corporation (NYSE:BLCO - Get Free Report) has been given an average recommendation of "Hold" by the eleven analysts that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating on the company. The average 12 month price objective among analysts that have covered the stock in the last year is $15.5556.

Several research analysts recently issued reports on BLCO shares. Evercore ISI increased their price objective on Bausch + Lomb from $15.50 to $16.00 and gave the stock an "outperform" rating in a research note on Tuesday, July 8th. HC Wainwright increased their price objective on Bausch + Lomb from $15.00 to $16.00 and gave the stock a "buy" rating in a research note on Thursday, July 31st. Barclays dropped their price objective on Bausch + Lomb from $19.00 to $16.00 and set an "equal weight" rating on the stock in a research note on Monday, June 9th. Wells Fargo & Company increased their price objective on Bausch + Lomb from $12.00 to $15.00 and gave the stock an "equal weight" rating in a research note on Thursday, July 31st. Finally, Citigroup increased their price objective on Bausch + Lomb from $13.00 to $15.00 and gave the stock a "neutral" rating in a research note on Wednesday, July 9th.

Bausch + Lomb Trading Up 1.5%

Shares of NYSE BLCO traded up $0.23 during midday trading on Friday, hitting $15.13. The company's stock had a trading volume of 322,647 shares, compared to its average volume of 513,752. The company has a current ratio of 1.55, a quick ratio of 0.98 and a debt-to-equity ratio of 0.76. The business's 50 day moving average is $14.39 and its two-hundred day moving average is $13.42. Bausch + Lomb has a 12-month low of $10.45 and a 12-month high of $21.69. The firm has a market cap of $5.36 billion, a P/E ratio of -19.40, a price-to-earnings-growth ratio of 1.52 and a beta of 0.63.

Bausch + Lomb (NYSE:BLCO - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.01. Bausch + Lomb had a positive return on equity of 2.33% and a negative net margin of 5.58%.The firm had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.25 billion. During the same period in the prior year, the business posted $0.13 earnings per share. The company's revenue for the quarter was up 5.1% on a year-over-year basis. Bausch + Lomb has set its FY 2025 guidance at EPS. As a group, equities research analysts expect that Bausch + Lomb will post 0.74 EPS for the current year.

Institutional Trading of Bausch + Lomb

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Squarepoint Ops LLC boosted its position in Bausch + Lomb by 359.3% during the 2nd quarter. Squarepoint Ops LLC now owns 50,892 shares of the company's stock valued at $662,000 after acquiring an additional 70,516 shares in the last quarter. Engineers Gate Manager LP boosted its position in Bausch + Lomb by 210.3% during the 2nd quarter. Engineers Gate Manager LP now owns 31,970 shares of the company's stock valued at $416,000 after acquiring an additional 21,668 shares in the last quarter. BNP Paribas Financial Markets bought a new stake in Bausch + Lomb during the 2nd quarter valued at $592,000. PDT Partners LLC boosted its position in Bausch + Lomb by 182.3% during the 2nd quarter. PDT Partners LLC now owns 172,209 shares of the company's stock valued at $2,240,000 after acquiring an additional 111,206 shares in the last quarter. Finally, Glenview Capital Management LLC boosted its position in Bausch + Lomb by 210.8% during the 2nd quarter. Glenview Capital Management LLC now owns 1,553,855 shares of the company's stock valued at $20,216,000 after acquiring an additional 1,053,855 shares in the last quarter. Institutional investors own 11.07% of the company's stock.

Bausch + Lomb Company Profile

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief.